Mesoblast
Price & Volume
Stats
See more52W Range | $9.88-$21.50 |
Market Cap | $1.9B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $65.3M |
Revenue Growth (YoY) | 1,526.8% |
Gross Profit (12 Mos) | -$23.2M |
Diluted EPS | -$0.72 |
News
See moreYahoo Finance • 27 days ago
Mesoblast Reports Ryoncil® Net Revenues of US$30.3m and Improved Net Operating Cash Spend for the Quarter to US$4.1 Million
Yahoo Finance • 28 days ago
Assessing Mesoblast’s Valuation After Recent Share Price Weakness And Conflicting Growth Signals
Yahoo Finance • 28 days ago
Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain
Yahoo Finance • last month
Mesoblast Limited (MESO), One of the Best Long-Term ASX Stocks To Buy Right Now; See Why
About
CEO | Dr. Silviu Itescu FACP, FACRA, FRACP, MBBS (Hons) |
Address | 55 Collins Street, Melbourne, VIC, Australia, 3000 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 81 |